Asthma-related microbes: Difference between revisions
CSV import |
No edit summary |
||
| Line 1: | Line 1: | ||
Asthma is a chronic inflammatory disease of the airways characterized by variable and recurring symptoms, airflow obstruction, and bronchospasm. Recent studies have suggested that certain microbes may play a role in the development and exacerbation of asthma. This article explores the relationship between asthma and specific microbes, including [[Chlamydia pneumoniae]], [[Mycoplasma pneumoniae]], and [[Human rhinovirus]]. | Asthma is a chronic inflammatory disease of the airways characterized by variable and recurring symptoms, airflow obstruction, and bronchospasm. Recent studies have suggested that certain microbes may play a role in the development and exacerbation of asthma. This article explores the relationship between asthma and specific microbes, including [[Chlamydia pneumoniae]], [[Mycoplasma pneumoniae]], and [[Human rhinovirus]]. | ||
| Line 9: | Line 7: | ||
== Mycoplasma pneumoniae == | == Mycoplasma pneumoniae == | ||
[[Mycoplasma pneumoniae]] is a type of bacteria that lacks a cell wall and is known to cause atypical pneumonia. It has also been associated with asthma exacerbations. M. pneumoniae can trigger immune responses that lead to increased airway inflammation and hyperreactivity, which are hallmarks of asthma. The presence of M. pneumoniae in the respiratory tract of asthmatic patients may contribute to the severity and frequency of asthma attacks. | [[Mycoplasma pneumoniae]] is a type of bacteria that lacks a cell wall and is known to cause atypical pneumonia. It has also been associated with asthma exacerbations. M. pneumoniae can trigger immune responses that lead to increased airway inflammation and hyperreactivity, which are hallmarks of asthma. The presence of M. pneumoniae in the respiratory tract of asthmatic patients may contribute to the severity and frequency of asthma attacks. | ||
| Line 23: | Line 19: | ||
* [[Inflammation]] | * [[Inflammation]] | ||
* [[Immune response]] | * [[Immune response]] | ||
{{stub}} | |||
[[Category:Asthma]] | [[Category:Asthma]] | ||
[[Category:Microbiology]] | [[Category:Microbiology]] | ||
[[Category:Respiratory diseases]] | [[Category:Respiratory diseases]] | ||
Latest revision as of 15:57, 21 February 2025
Asthma is a chronic inflammatory disease of the airways characterized by variable and recurring symptoms, airflow obstruction, and bronchospasm. Recent studies have suggested that certain microbes may play a role in the development and exacerbation of asthma. This article explores the relationship between asthma and specific microbes, including Chlamydia pneumoniae, Mycoplasma pneumoniae, and Human rhinovirus.
Chlamydia pneumoniae[edit]
Chlamydia pneumoniae is a species of bacteria that can cause respiratory tract infections. It has been implicated in the exacerbation of asthma symptoms. The bacterium is known to infect the epithelial cells of the respiratory tract, leading to inflammation and potentially worsening asthma control. Studies have shown that patients with asthma may have a higher prevalence of C. pneumoniae infection compared to non-asthmatic individuals.
Mycoplasma pneumoniae[edit]
Mycoplasma pneumoniae is a type of bacteria that lacks a cell wall and is known to cause atypical pneumonia. It has also been associated with asthma exacerbations. M. pneumoniae can trigger immune responses that lead to increased airway inflammation and hyperreactivity, which are hallmarks of asthma. The presence of M. pneumoniae in the respiratory tract of asthmatic patients may contribute to the severity and frequency of asthma attacks.
Human rhinovirus[edit]
Human rhinovirus is a common viral infectious agent that causes the common cold. It is one of the most frequent triggers of asthma exacerbations, especially in children. The virus infects the upper respiratory tract and can lead to increased airway inflammation and obstruction in asthmatic individuals. Rhinovirus infections are associated with increased morbidity in asthma patients, and managing these infections is crucial for controlling asthma symptoms.
